Medicine and Dentistry
Psoriasis
100%
Melanoma
32%
Disease
29%
Systemic Therapy
19%
Drug Therapy
19%
Tumor Necrosis Factor
17%
Syphilis
16%
Vitiligo
16%
Alpha Adrenergic Receptor Blocking
16%
Calcineurin Inhibitor
16%
Systemic Vascular Resistance
16%
Metabolic Syndrome
16%
Arm
16%
Leg
16%
Immunosuppressive Drug
16%
Pemphigus vulgaris
16%
Punch Biopsy
16%
Cohort Effect
16%
Combined Therapy
13%
Skin Cancer
12%
Phototherapy
11%
Dermatosis
11%
Physician
10%
Human Immunodeficiency Virus
10%
Lyme Borreliosis
10%
Blister
10%
Comorbidity
8%
Immune System
8%
Differential Diagnosis
8%
Kaposi Sarcoma
8%
Malignant Neoplasm
8%
Biological Product
7%
Dermatitis
6%
Scalp
6%
Immunosuppressive Treatment
6%
TNF Inhibitor
6%
Blood Flow
5%
Diagnosis
5%
Pigmentation
5%
Varices
5%
Staphylococcus Aureus
5%
Secondary Syphilis
5%
Immunoglobulin E
5%
Hemolytic
5%
Treatment Interruption
5%
Eczema
5%
Diagnostic Accuracy
5%
Papule
5%
Alpha 2 Globulin
5%
Streptococcus pyogenes
5%
Pharmacology, Toxicology and Pharmaceutical Science
Psoriasis
67%
Ceftriaxone
19%
Methotrexate
16%
Metabolic Syndrome X
16%
Cohort Study
16%
Syphilis
16%
Antiinfective Agent
16%
Microflora
16%
Atopic Dermatitis
16%
Staphylococcus Aureus
12%
Monotherapy
11%
Microorganism
9%
Ciprofloxacin
9%
Erythromycin
9%
Biological Product
7%
Psoriasis Vulgaris
7%
Coagulase
6%
Penicillin Derivative
6%
Tetracycline
6%
Disease
6%
Immunology and Microbiology
Comorbidity
29%
Blood Flow
21%
Biological Product
16%
Alpha Adrenergic Receptor Blocking
16%
Systemic Vascular Resistance
16%
Microflora
16%
Tumor Necrosis Factor Alpha
16%
Adalimumab
16%
Atopic Dermatitis
16%
Staphylococcus Aureus
12%
Immune System
10%
Microorganism
9%
Lipid Metabolism
8%
Growth Factor
8%
Laser Flowmeter
8%
Population
8%
Perfusion
8%
Cytokine
8%
Blood Pressure
8%
Glucose Metabolism
8%
Coagulase
6%
Blood Vessels
5%
